Apheon
Apheon Advisors France S.A is a pan-European mid-market private equity firm founded in 2005, managing approximately €4.5 billion in assets and investing primarily in companies headquartered in Benelux, France, Germany, Italy, and Spain. The firm focuses on sustainable finance and transforming companies through partnership with management teams and families.
Apheon is a PARIS buyout firm with €4.5B AUM, 27 active companies and 27 exits.
- ·16 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 25 realized deals: 5 years.
- ·Top sector focus: Consumer (33% of portfolio).
- ·Fund cadence: ~3Y between vintages · last raise 2025.
Sector breakdown
54 companiesGeography breakdown
6 geographiesKey facts
Recent exits
Apheon sold Ortivity to Unigestion and selected new Apheon investors in 2025 after 3 years.
Apheon sold Lyceo to Capital A Investment Partners in 2025 after 4 years.
Apheon sold Haudecoeur to Apheon TMC HDC Long Term Value Fund SCSp; LFPI acquired a minority stake in 2024 after less than a year.
Apheon sold TMC to Apheon TMC HDC Long Term Value Fund SCSp; MML Capital acquired a minority stake in 2024 after less than a year.
Coverage notes
9 funds tracked, 54 portfolio companies (27 active · 27 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund Apheon has raised, with its portfolio companies. Hand-checked from public filings.
AMB VIBuyout2025€1.3B8 assetsBuyout2025 · 1yr€1.3B8–
Unrealized
8 held| Company | Entry |
|---|---|
| Alma Fintech · Belgium | 2026 |
| Diagnostica Longwood Healthcare · Spain | 2025 |
| Easi IT Services · Belgium | 2026 |
| Global Trenchless Solutions Construction · Netherlands | 2025 |
| Golmar Consumer · Italy | 2025 |
| Hittech Industrials · Netherlands | 2024 |
| Rubio Monocoat Industrials · Belgium | 2026 |
| Teknimed MedTech · France | 2026 |
AMB V ContinuationBuyout2024€435M0 assets2 exitsBuyout2024 · 2yr€435M02
Realized
2 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Haudecoeur Consumer · France | 2024 | 2024 | Continuation Vehicle | Apheon TMC HDC Long Term Value Fund SCSp; LFPI acquired a minority stake | – |
| TMC Business Services · Netherlands | 2024 | 2024 | Continuation Vehicle | Apheon TMC HDC Long Term Value Fund SCSp; MML Capital acquired a minority stake | – |
AMB VBuyout2022€800M6 assets1 exitsBuyout2022 · 4yr€800M61
Unrealized
6 held| Company | Entry |
|---|---|
| 360 Padel Group E-commerce · Spain | 2022 |
| AlliA Financials · Belgium | 2023 |
| Fiabila Consumer · Belgium | 2024 |
| Salpa Consumer · Italy | 2023 |
| Salpa & Cherubini Consumer · Italy | 2023 |
| Satlink TMT · Spain | 2022 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Ortivity Healthcare · Germany | 2022 | 2025 | Secondary | Unigestion and selected new Apheon investors | – |
AMB IV ContinuationBuyout2021€200M2 assetsBuyout2021 · 5yr€200M2–
AMB III ContinuationBuyout20191 assetsBuyout2019 · 7yr–1–
Unrealized
1 held| Company | Entry |
|---|---|
| Opseo Healthcare · Germany | 2019 |
AMB IVBuyout2019€580M6 assets6 exitsBuyout2019 · 7yr€580M66
Unrealized
6 held| Company | Entry |
|---|---|
| CompaNanny Consumer · Netherlands | 2020 |
| Fair Doctors Healthcare · Germany | 2021 |
| Millbio Consumer · Belgium | 2020 |
| Summa Industrials · Netherlands | 2021 |
| Telenco Industrials · France | 2020 |
| VidaCura Healthcare · Germany | 2021 |
Realized
6 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Dolciaria Acquaviva Consumer · Italy | 2019 | 2024 | Trade Sale | Vandemoortele | – |
| Haudecoeur Consumer · France | 2019 | 2024 | Continuation Vehicle | Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + LFPI-backed continuation fund) | – |
| Lyceo EdTech · Netherlands | 2021 | 2025 | Secondary | Capital A Investment Partners | – |
| Palex MedTech · Spain | 2020 | 2021 | Secondary | Fremman Capital | – |
| Sofico SaaS · Belgium | 2020 | 2024 | Secondary | Astorg | – |
| TMC Business Services · Netherlands | 2019 | 2024 | Continuation Vehicle | Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + MML Capital-backed continuation fund) | – |
AMB IIIBuyout2014€340M2 assets9 exitsBuyout2014 · 12yr€340M29
Unrealized
2 held| Company | Entry |
|---|---|
| Sausalitos Hospitality · Germany | 2014 |
| Stationery Care Group Consumer · Netherlands | 2015 |
Realized
9 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Golden Goose Consumer · Italy | 2015 | 2017 | Trade Sale | The Carlyle Group | – |
| Indo Healthcare · Spain | 2018 | 2022 | Trade Sale | Rodenstock | – |
| IPE Visionnaire Consumer · Italy | 2014 | 2024 | Trade Sale | FOREL (Marco Bizzarri-backed Italian investment co) | – |
| Keesing Media Group Consumer · Netherlands | 2017 | 2021 | Secondary | BC Partners | – |
| Looping Hospitality · Belgium | 2016 | 2019 | Secondary | Mubadala Capital | – |
| Opseo Healthcare · Germany | 2016 | 2019 | Continuation Vehicle | AMB III Continuation Fund | – |
| Saverto Industrials · Belgium | 2018 | 2021 | Continuation Vehicle | AMB IV Continuation Fund | – |
| SVT Industrials · Germany | 2018 | 2021 | Continuation Vehicle | AMB IV Continuation Fund | – |
| Vanreusel Consumer · Belgium | 2018 | 2023 | MBO | Vanreusel family (management buyback) | – |
AMB IIBuyout2010€200M2 assets1 exitsBuyout2010 · 16yr€200M21
Unrealized
2 held| Company | Entry |
|---|---|
| Benito Industrials · Spain | 2011 |
| Group De Boeck Consumer · Belgium | 2011 |
Realized
1 exit| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| ELITech MedTech · France | 2010 | 2023 | Trade Sale | Bruker | – |
AMB IBuyout2005€150M0 assets8 exitsBuyout2005 · 21yr€150M08
Realized
8 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Corialis Construction · Belgium | 2007 | 2014 | Secondary | Advent International | – |
| Joris Ide Construction · Belgium | 2007 | 2015 | Trade Sale | Kingspan Holdings | – |
| King Consumer · Netherlands | 2006 | 2007 | Trade Sale | Bunzl plc | – |
| La Gardenia Consumer · Italy | 2006 | 2011 | Trade Sale | Bridgepoint | – |
| Nicotra Gebhardt Industrials · Germany | 2008 | 2018 | Trade Sale | Regal Beloit | – |
| Seves Industrials · Italy | 2007 | 2014 | Trade Sale | Triton Partners | – |
| Stroili Consumer · Italy | 2005 | 2016 | Trade Sale | THOM Europe | – |
| ZellBios Pharma · Germany | 2007 | 2013 | Trade Sale | Deutsche Private Equity | – |
About Apheon
Apheon is a pan-European mid-market private equity firm with €4.5 billion of assets under management as of December 2024, headquartered in Brussels with additional offices in Paris, Madrid, Milan and Luxembourg. The firm was founded in 2005 and rebranded from Ergon Capital Partners to Apheon in 2023, building on a two-decade track record across Benelux-anchored European mid-market investments. The platform is partner-owned and independent, with its operational base in Brussels reflecting the Benelux origins of the franchise.
Investment thesis
Apheon targets Benelux and selectively pan-European mid-cap LBO transactions with equity tickets ranging from €30 million to €150 million per transaction, focusing on profitable companies headquartered in or with significant operations across Belgium, the Netherlands, Luxembourg, France, Spain and Italy. Sector focus spans Consumer, Financials, Industrials, Healthcare, TMT, Software and Business Services. The firm emphasises operational value creation through management team partnership and selective bolt-on M&A strategies over five to seven year holding periods.
Recent activity
Recent realised exits include Lyceo (consumer, 2025), Haudecoeur (consumer, 2024), IPE Visionnaire (consumer, 2024), TMC (business services, 2024) and ELITech (healthcare, 2023), reflecting active distribution across the consumer and business services franchises. The platform tracks 9 funds, 33 active portfolio companies and 17 realised exits, with the latest vintage actively deploying capital across European mid-market opportunities under the Apheon brand.
Frequently asked questions
- What investment strategy does Apheon focus on?
- Apheon focuses on Buyout, Growth strategies in the private equity space.
- How many portfolio companies does Apheon have?
- Apheon has 27 active portfolio companies and 27 completed exits and 9 funds tracked on GP Intel.
- Where is Apheon headquartered?
- Apheon is headquartered in PARIS, Belgium.
- What is Apheon's assets under management?
- Apheon manages approximately €4.5B in assets under management.
- When was Apheon founded?
- Apheon was founded in 2010.
- What sectors does Apheon invest in?
- Apheon invests across Healthcare, Consumer, Business Services, Industrials.
- What are Apheon's recent exits?
- Recent realized exits by Apheon include: Ortivity (2025) to Unigestion and selected new Apheon investors; Lyceo (2025) to Capital A Investment Partners; Haudecoeur (2024) to Apheon TMC HDC Long Term Value Fund SCSp; LFPI acquired a minority stake; TMC (2024) to Apheon TMC HDC Long Term Value Fund SCSp; MML Capital acquired a minority stake; Dolciaria Acquaviva (2024) to Vandemoortele; Haudecoeur (2024) to Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + LFPI-backed continuation fund); Sofico (2024) to Astorg; TMC (2024) to Apheon TMC HDC Long Term Value Fund SCSp (HarbourVest + MML Capital-backed continuation fund).
Similar firms
Other private equity firms tracked on GP Intel.